Evaluation of the use of Urocath-Gel catheters for intermittent self-catheterization by male patients using conventional catheters for a long time.
METHODS
Prospective study of intermittent self-catheterization (CIC) with change from conventional catheter to low-friction Urocath-Gel catheter.


OBJECTIVE
To evaluate if such catheters are well accepted and to evaluate their practical use.


METHODS
Thirty-nine male patients, between 19 and 74 years old, performing clean intermittent self-catheterization with conventional catheters for a neuropathic bladder for many years were included in this study after written informed consent. Exclusion criteria were clinical urinary tract infection, acute infection of urethra, prostate or epididymis, untreated urethral strictures and false passages or severe urethral bleeding occurring within the last month. During 1 month they changed to the use of the Urocath-Gel catheter. Complications were noted. Satisfaction was evaluated by a visual analogue scale and by questioning.


RESULTS
Four patients did not complete the study, two for side effects, two for difficulties with the catheterization technique. Time needed for CIC was not different with both techniques. Difficult introduction or difficult retreat of the catheter were not different in frequency. Impossibility to introduce the catheter was less frequent. Urethritis and urethral bleeding were less frequent than during the use of conventional catheters. Satisfaction was better with the low friction catheters. Negative satisfaction was mainly related to the availability and the use of water to lubricate the catheter, difficulty of manipulation and fear for cost.


CONCLUSIONS
The hydrophilic catheter Urocath-Gel proved as easy to use as conventional catheters but was better tolerated. Satisfaction was better especially in patients who experienced problems with conventional catheters. Some patients were unsatisfied for reasons of practical use or for economical reasons.
Wyndaele
J
J
Department of Urology, Universitair ziekenhuis, Edegem, Belgium.
De Ridder
D
D
Everaert
K
K
Heilporn
A
A
Congard-Chassol
B
B
D000328:Adult; D000368:Aged; D002404:Catheterization / Q000009:adverse effects / Q000592:standards*; D020099:Coated Materials, Biocompatible / Q000592:standards*; D005069:Evaluation Studies as Topic; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D012648:Self Care; D013118:Spinal Cord Diseases / Q000628:therapy*; D014522:Urethral Diseases / Q000209:etiology; D014526:Urethritis / Q000209:etiology; D001750:Urinary Bladder, Neurogenic / Q000628:therapy*
D020099:Coated Materials, Biocompatible